Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ElleVet Mobility Soft Chews is a veterinary nutraceutical developed by ElleVet Sciences specifically for canine health. The formulation features a proprietary full-spectrum hemp oil rich in cannabidiol (CBD) and cannabidiolic acid (CBDA), combined with joint-supportive agents glucosamine and chondroitin. It is primarily indicated for managing joint discomfort and improving mobility in dogs, while also addressing secondary issues such as stress, anxiety, and age-related cognitive decline. The product's efficacy has been validated through clinical research at the Cornell University College of Veterinary Medicine, demonstrating significant improvement in dogs with multi-joint pain. The cannabinoids interact with the endocannabinoid system to modulate pain and inflammation, while glucosamine and chondroitin support cartilage health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ElleVet Mobility Soft Chews.